**4**
## **Trustees’ Annual Report for the period**
**From 01/04/2023 To 31/03/2024**
**Charity name:** United Kingdom and Ireland Oesophagogastric Cancer Group
## **Charity registration number:** 1198358
## **Objectives and Activities**
||SORP reference||
|---|---|---|
|Summary of the purposes
of the charity as set out in
its governing document|Para 1.17|For the public benefit, the advancement of
health and saving of lives by (but not limited to)
the following means: a) providing a forum to
share knowledge and for discussion about
medical cases in the field of oncology; b)
providing information and advice to those who
work in the field of oncology about care and
treatment of cancers, including but not limited
to oesophageal and gastric cancer; and c)
carrying out such other charitable activities as
the trustees see fit from time to time which
would improve the standard of care and
treatment of oesophageal and gastric cancer
patients and cancerpatientsgenerally.|
|Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|•
Provides
education/advocacy/advice/information
•
Workshops, conferences, seminars
and/or lectures
•
professional training|
|Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|THE UKIOG Charity aims to improve
outcomes for Oesophago gastric cancer
patients by sharing of best practice,
supporting research and facilitating training.
All of these activities are aimed at ultimately
improving the care of cancer patients and
therefore are a benefit to the public.|
## **Additional information (optional)** You may choose to include further statements where relevant about:
SORP reference UKIOG does not presently make grants. Para 1.38 Policy on grant making
|Policy on social investment
including program related
investment|Para 1.38|UKIOG does not carry out social
investments.|
|---|---|---|
|Contribution made by
volunteers|Para 1.38|The founders, steering group and
committees are formed of volunteers who
provide their time free of charge.
The only payments made are to faculty /
speakers to support their attendance at the
face to face meetings.|
|Other|||
## **Achievements and Performance**
||SORP reference||
|---|---|---|
|Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|The charity has successfully run 3 virtual
National MDTs where complex cancer
cases are discussed and then learnings
from these cases disseminated. This has
harmonised best practice and highlighted
where centres are offering procedures or
other treatments not on offer in other
centres. This has directly led to the transfer
of patients care to super specialist centres.
We also ran our second face to face annual
event meeting attended by 150 people from
across all the healthcare professions who
look after Oesophageal and gastric cancer
patients. This meeting highlighted the latest
areas of research and shared best practice
in managing these complex patients.
Feedback from this meeting was extremely
positive with 97.3% of people stating they
were highly satisfied with the event overall.
We hosted our first UKIOG webinar which
was attended by 190 people from across all
the healthcare professions who look after
Oesophageal and gastric cancer patients.
Feedback from this meeting was extremely
positive with 92% of people stating they
would recommend the webinar to
professional colleagues.|
**Additional information (optional)** You may choose to include further statements where relevant about:
We achieved our goals for this period.
|Achievements against
objectives set|Para 1.41||
|---|---|---|
|Performance of fundraising
activities against objectives
set|Para 1.41|We fund our activities via sponsorship from
medical companies. This pays for the
events and the remaining money is then
available for other activities.|
|Investment performance
against objectives|Para 1.41|N/A|
|Other|||
## **Financial Review**
|**Financial Review**|||
|---|---|---|
|Review of the charity’s
financial position at the end
of the period|Para 1.21|We ended the financial period with a sum
of £29,765. We have no other assets and
no liabilities.|
|Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|We don’t aim to keep a reserve, but the
sum left at the end of this financial year is
to allow us to prepare for the subsequent
years activities, cover secretarial support
and to invest in a professional website to
allow us to disseminate the training
materials we have created.|
|Amount of reserves held|Para 1.22|N/A|
|Reasons for holding zero
reserves|Para 1.22|N/A|
|Details of fund materially in
deficit|Para 1.24|N/A|
|Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|N/A|
|**Additional information (optional)**
You may choose to include further statements|**Additional information (optional)**
You may choose to include further statements|where relevant about:|
|---|---|---|
|The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|Sponsorship from medical companies.|
|Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|N/A|
|A description of the principal
risks facing the charity|Para 1.46|None at present. After the first sponsored
events the sponsors have made it clear
they are very happy to continue sponsoring
more events.|
|Other|||
## **Structure, Governance and Management**
|Description of charity’s
trusts:||N/A|
|---|---|---|
|Type of governing document
(trust deed, royal charter)|Para 1.25|CIO Constitution.|
|How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|CIO|
|Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|The current three trustees were
responsible for the creation of UKIOG and
its formation as a charity. New trustees will
be appointed as required by a process of
self nomination and then voting by the
steering committee and all the sub
committees that form UKIOG|
**Additional information (optional)** You may choose to include further statements where relevant about:
|Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|We will use the Charity Excellence
Framework courses to trainee new
trustees.|
|---|---|---|
|The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|The charity is formed of the three trustees,
a steering committee and then a Research
Committee. Additional committees will be
set up of the course of 2024.|
|Relationship with any
related parties|Para 1.51|**None**|
|Other|||
## **Reference and Administrative details**
|Charity name|United Kingdom and Ireland Oesophagogastric Cancer Group|
|---|---|
|Other name the charity uses||
|Registered charitynumber|1198358|
|Charity’s principal address|Velindre Cancer Centre,
Velindre Road,
Whitchurch,
Cardiff,
CF14 2TL|
|||
## **Names of the charity trustees who manage the charity**
|1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Thomas Crosby||||
||Christopher Peters||||
||Elizabeth Smyth||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
## – Corporate trustees names of the directors at the date the report was approved
**Director name** N/A
Name of trustees holding title to property belonging to the charity
|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|None|||
||||
||||
||||
||||
||||
## **Funds held as custodian trustees on behalf of others**
Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets
## **Additional information (optional)**
## **Names and addresses of advisers (Optional information)**
|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|
|---|---|---|
|**Type of**
**adviser**
**Name**
**Address**|||
||||
||||
||||
||||
|**Name of chief executive or names of senior staff members (Optional information)**|||
||||
## **Exemptions from disclosure**
Reason for non-disclosure of key personnel details
N/A
## **Other optional information**
N/A
## **Declarations**
**The trustees declare that they have approved the trustees’ report above.**
**Signed on behalf of the charity’s trustees**
|**Signature(s)**
**Full name(s)**
**Position (eg Secretary,**
**Chair, etc)**
**Date**|||
|---|---|---|
||Prof Thomas Crosby||
||
Trustee||
||17.10.24||
||17.10.24||
|Date|Description|Income Money IN|Expense Money OUT|Overall Balance|
|---|---|---|---|---|
|05/04/2023|Payment for website||£1.20|£31,070.04|
|02/05/2023|Admin Payment for work carried out||£1,180|£29,890.04|
|09/05/2023|Payment for website||£40.80|£29,849.24|
|23/05/2023|Admin Payment for work carried out||£96|£29,753.24|
|07/06/2023|Payment for website||£10.80|£29,742.44|
|14/06/2023|Further invoice for Royal Society of
Medicine for Event - Annual Meeting||£2,000|£27,742.44|
|06/07/2023|Payment for website||£10.80|£27,731.64|
|07/08/2023|Payment for website||£10.80|£27,720.84|
|14/08/2023|Further invoice for Royal Society of
Medicine for Event - Annual Meeting||£2,000|£25,270.84|
|06/09/2023|Payment for website||£10.80|£25,710.04|
|06/10/2023|Payment for website||£10.80|£25,699.24|
|07/11/2023|Payment for website||£10.80|£25,688.44|
|06/12/2023|Payment for website||£10.80|£25,677.64|
|13/12/2023|Payment for development of new
website - John Chipperfield||£5,000|£20,677.64|
|18/12/2023|Payment for development of new
website - John Chipperfield||£1,000|£19,677.64|
|04/01/2024|Payment to Media 1 Productions for
2024 Annual Meeting||£3,390|£16,287.64|
|05/01/2024|Payment for website||£10.80|£16,276.84|
|05/02/2024|Payment to Royal Society of Medicine
for Event - Annual Meeting2024||£3,240|£13,036.84|
|07/02/2024|Payment for website||£10.80|£13,026.04|
|23/02/2024|Sponsorship from Amgen for Annual
Meeting2024|£10,000||£23,026.04|
|01/03/2024|Sponsorship from Servier for Annual
Meeting2024|£1,500||£24,526.04|
|07/03/2024|Payment for website||£10.80|£24,515.24|
|18/03/2004|Cook UK Sponsorship of Annual
Meeting2024|£2,500||£27,015.24|
|---|---|---|---|---|
|18/03/2004|Biohit Healthcare UK Sponsorship of
Annual Meeting2024|£2,750||£29,765.24|
Total Current Assets 0 Total Current Liabilities 0